The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome
Open accessAbstract
PurposeImmunoparalysis defined by prolonged monocyte human leukocyte antigen DR depression is associated with adverse outcomes in adult severe sepsis and can be reversed with granulocyte macrophage colony-stimulating factor (GM-CSF). We hypothesized that immunoparalysis defined by whole-blood ex vivo lipopolysaccharide-induced tumor necrosis factor-alpha (TNFα) response <200 pg/mL beyond day 3 of multiple organ dysfunction syndrome (MODS) is similarly associated with nosocomial infection in children and can be reversed with GM-CSF.MethodsIn study period 1, we performed a multicenter cohort trial of transplant and nontransplant multiple organ dysfunction syndrome (MODS) patients (≥2 organ failure). In study period 2, we performed an open-label randomized trial of GM-CSF therapy for nonneutropenic, nontransplant, severe MODS patients (≥3 organ failure) with TNFα response <160 pg/mL.ResultsImmunoparalysis was observed in 34% of MODS patients (n = 70) and was associated with increased nosocomial infection (relative risk [RR] 3.3, 95% confidence interval [1.8–6.0] p < 0.05) and mortality (RR 5.8 [2.1–16] p < 0.05). TNFα response <200 pg/mL throughout 7 days after positive culture was associated with persistent nosocomial infection, whereas recovery above 200 pg/mL was associated with resolution of infection (p < 0.05). In study period 2, GM-CSF therapy facilitated rapid recovery of TNFα response to >200 pg/mL by 7 days (p < 0.05) and prevented nosocomial infection (no infections in seven patients versus eight infections in seven patients) (p < 0.05).ConclusionsSimilar to in adults, immunoparalysis is a potentially reversible risk factor for development of nosocomial infection in pediatric MODS. Whole-blood ex vivo TNFα response is a promising biomarker for monitoring this condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISM III: An updated Pediatric Risk of Mortality score
Pollack, M. M., Patel, K. M., & Ruttimann, U. E. (1996) · Critical Care Medicine · doi:10.1097/00003246-199605000-00004 · Cited by 1,759
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190
Self-citationSir Isaac Newton, sepsis, SIRS, and CARS
Bone, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00010 · Cited by 989
Kellum, J. A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1655 · Cited by 828
Meisel, C., Schefold, J. C., Pschowski, R., Baumann, T., Hetzger, K., Gregor, J., Weber-Carstens, S., Hasper, D., Keh, D., Zuckermann, H., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0363oc · Cited by 648
Self-citationPersisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock
Monneret, G., Lepape, A., Voirin, N., Bohé, J., Venet, F., Debard, A.-L., Thizy, H., Bienvenu, J., Gueyffier, F., & Vanhems, P. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0204-8 · Cited by 545
Monocyte deactivation-rationale for a new therapeutic strategy in sepsis
Volk, H. D., Reinke, P., Krausch, D., Zuckermann, H., Asadullah, K., Müller, J. M., Döcke, W. D., & Kox, W. J. (1996) · Intensive Care Medicine · doi:10.1007/bf01743727 · Cited by 361
Self-citationMonocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient
Hershman, M. J., Cheadle, W. G., Wellhausen, S. R., Davidson, P. F., & Polk, H. C. (1990) · Journal of British Surgery · doi:10.1002/bjs.1800770225 · Cited by 348
Induction of Interleukin 6 (IL-6) by Hypoxia in Vascular Cells
Yan, S. F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., Brett, J., May, L., & Stern, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11463 · Cited by 345
Felmet, K. A., Hall, M. W., Clark, R. S. B., Jaffe, R., & Carcillo, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3765 · Cited by 264
Self-citationMonneret, G., Finck, M.-E., Venet, F., Debard, A.-L., Bohé, J., Bienvenu, J., & Lepape, A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.07.009 · Cited by 250
Clinical Aspects: From Systemic Inflammation to 'Immunoparalysis�
Volk, H.-D., Reinke, P., & D�cke, W.-D. (1999) · Chemical Immunology and Allergy · doi:10.1159/000058753 · Cited by 233
Self-citationPresneill, J. J., Harris, T., Stewart, A. G., Cade, J. F., & Wilson, J. W. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009005 · Cited by 208
Fumeaux, T., & Pugin, J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200203-217oc · Cited by 200
Kox, W. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440250031004 · Cited by 160
Nierhaus, A., Montag, B., Timmler, N., Frings, D. P., Gutensohn, K., Jung, R., Schneider, C. G., Pothmann, W., Brassel, A. K., & Esch, J. S. A. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1666-6 · Cited by 145
Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure
Doughty, L., Kaplan, S. S., & Carcillo, J. A. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00012 · Cited by 120
Self-citationImmunoparalysis in patients with severe trauma and the effect of inhaled interferon-γ*
Nakos, G., Malamou‐Mitsi, V., Lachana, A., Karassavoglou, A., Kitsiouli, E., Agnandi, N., & Lekka, M. E. (2002) · Critical Care Medicine · doi:10.1097/00003246-200207000-00015 · Cited by 119
Bundschuh, D. S., Barsig, J., Härtung, T., Randow, F., Döcke, W. D., Volk, H., & Wendel, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2862 · Cited by 111
Self-citationGREEN TEA POLYPHENOL EXTRACT ATTENUATES ZYMOSAN-INDUCED NON-SEPTIC SHOCK IN MICE
Paola, R. D., Mazzon, E., Muià, C., Crisafulli, C., Genovese, T., Bella, P. D., Esposito, E., Menegazzi, M., Meli, R., Suzuki, H., et al. (2006) · Shock · doi:10.1097/01.shk.0000191379.62897.1d · Cited by 109
Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery*
Allen, M. L., Hoschtitzky, J. A., Peters, M. J., Elliott, M. J., Goldman, A. P., James, I., & Klein, N. J. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000240243.28129.36 · Cited by 101
Rosenbloom, A. J., Linden, P. K., Dorrance, A. M., Penkosky, N., Cohen-Melamed, M. H., & Pinsky, M. R. (2005) · CHEST Journal · doi:10.1378/chest.127.6.2139 · Cited by 91
Flohé, S., Lendemans, S., Selbach, C., Waydhas, C., Ackermann, M., Schade, F. U., & Kreuzfelder, E. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000089640.17523.57 · Cited by 62
Ho, Y., Sheen, I., Chiu, C., Wu, C., & Lin, C. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00495.x · Cited by 56
Woiciechowsky, C., Asadullah, K., Nestler, D., Schöning, B., Glöckner, F., Döcke, W., & Volk, H. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00236-1 · Cited by 38
Self-citationHoffman, J. A., Weinberg, K. I., Azen, C., Horn, M. V., Dukes, L., Starnes, V. A., & Woo, M. S. (2004) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2004.00069.x · Cited by 36
Lendemans, S., Kreuzfelder, E., Waydhas, C., Schade, F. U., & Flohé, S. (2007) · Inflammation Research · doi:10.1007/s00011-007-6069-7 · Cited by 28
Cited by
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
The immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70001-x · Cited by 1,442
Global Epidemiology of Pediatric Severe Sepsis: The Sepsis Prevalence, Outcomes, and Therapies Study
Weiss, S. L., Fitzgerald, J. C., Pappachan, J., Wheeler, D., Jaramillo-Bustamante, J. C., Salloo, A., Singhi, S. C., Erickson, S., Roy, J. A., Bush, J. L., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201412-2323oc · Cited by 1,043
Advances in the understanding and treatment of sepsis-induced immunosuppression
Venet, F., & Monneret, G. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.165 · Cited by 981
Metadata
- Authors
- Hall, M. W., Knatz, N. L., Vetterly, C., Tomarello, S., Wewers, M. D., Volk, H. D., & Carcillo, J. A.
- Venue
- Intensive Care Medicine
- Published
- 2010-12-10
- Volume
- 37
- Issue
- 3
- Pages
- 525-532
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W1983691837
- Cited by
- 355
- References
- 27
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.